DAFNA Capital Management LLC
Top Portfolio Positions
79 positions ·
$382,680,155 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
580,678 | $56,470,935 | 14.76% |
| STXS |
Stereotaxis, Inc.
Healthcare
|
13,680,554 | $25,172,219 | 6.58% |
| DAWN |
Day One Biopharmaceuticals, Inc.
Healthcare
|
978,463 | $20,978,246 | 5.48% |
| ATRC |
AtriCure, Inc.
Healthcare
|
597,431 | $17,044,706 | 4.45% |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
476,740 | $15,884,976 | 4.15% |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
250,772 | $14,582,391 | 3.81% |
| CYTK |
Cytokinetics Inc
Healthcare
|
217,497 | $14,335,227 | 3.75% |
| CMPS |
COMPASS Pathways plc
Healthcare
|
2,418,882 | $13,376,417 | 3.50% |
| NKTR |
Nektar Therapeutics
Healthcare
|
165,178 | $11,884,557 | 3.11% |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
443,829 | $9,586,706 | 2.51% |
Holdings in DNLI
Export CSV
1 of 1 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,115,200 | 318,500 | Shares | Sole | 2026-05-15 | |
| No quarters match your search. | ||||||